MENVEO

MENVEO [Meningococcal (Groups A, C, Y, and W-135) OligosaccharideDiphtheria CRM197 Conjugate Vaccine.Menveo is a vaccine designed to protect against meningococcal disease, a serious bacterial infection caused by Neisseria meningitidis. This infection can lead to meningitis, which is the inflammation of the protective membranes covering the brain and spinal cord, as well as septicemia, a life-threatening bloodstream infection. Meningococcal disease can progress rapidly and is potentially fatal, m

• ✓Meningococcal ACYW-135 oligosaccharide conjugate vaccine by GlaxoSmithKline
• ✓CRM197 diphtheria protein conjugation enhances immune response
• ✓Protects against meningitis and septicemia caused by four meningococcal serogroups
• ✓Recommended for travelers, adolescents, and immunocompromised individuals